Investing Profile

Debbie Lin

InvestorVC
Executive Director Boehringer Ingelheim Venture Fund | Digital Health at Boehringer Ingelheim Venture Fund
boehringer-ingelheim-venture....Cambridge, Massachusetts
Photo of Debbie Lin, Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Stanford University Network
925 CONNECTIONS
Roche Network
31 CONNECTIONS
Pomona College Network
26 CONNECTIONS
University of California, San Francisco Network
20 CONNECTIONS
cb
$100K - $5.0M
$1.5M
4
CompanyStageDateRound SizeTotal Raised
Optina Diagnostics
Series AOct 2021$20M
$23M
Co-investors: Barney Pell (Radical Ventures)
Bodyport
Series AAug 2020$11M
$16M
Co-investors: Bruce Leak (Playground Global), Garry Tan (Y Combinator)
Wellth
Series AMay 2020$10M
SeedSep 2018$5M
$73M
Co-investors: Yuanling Yuan (SignalFire), Igor Ryabenkiy (Altair Capital Management), Shamin Walsh (BAM VENTURES LLC), Shawn Ellis (Distributed Ventures), Ella Seitz (Esplanade HealthTech Ventures), Avi Savar (DreamIt Ventures), Steve Barsh (GIT1K)
Associate Consultant Pacific Health Policy GroupPresent
External Consultant RochePresent
Senior Manager Medical Affairs Boehringer IngelheimPresent
Associate Director Health Quality and Outcomes Boehringer IngelheimPresent
Head: US Making More Health Leader Boehringer Ingelheim's Corporate Social Responsibility program Boehringer IngelheimPresent
Boehringer Ingelheim Corporate Headquarters, GmBH HotmailPresent
Executive Director Boehringer Ingelheim Venture Fund | Digital Health Boehringer IngelheimPresent
Pomona College BS Chemistry and Public Policy
Stanford University MSc. Eng Management Science and Engineering
University of California, San Francisco PhD Bioinformatics Pharmacogenomics